Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein (Q40842217)

24 September 2017

Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein (English)

1 reference

24 September 2017

1 reference

3

1 reference

24 September 2017

7

J Hardy

1 reference

24 September 2017

L Ko

1

1 reference

24 September 2017

N D Mehta

2

1 reference

24 September 2017

C Easson

4

1 reference

24 September 2017

J Hussey

5

1 reference

24 September 2017

S Yen

6

1 reference

24 September 2017

S H Yen

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Journal of Neurochemistry

24 September 2017

1 reference

24 September 2017

75

1 reference

24 September 2017

6

1 reference

24 September 2017

2546-2554

1 reference

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

24 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Conformational properties of substrate proteins bound to a molecular chaperone alpha-crystallin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Widespread alterations of alpha-synuclein in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Low frequency of alpha-synuclein mutations in familial Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Protein nitration in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Identification of two distinct synucleins from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Modulated induction of tau proteins in cultured human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Bcl-2 gene family in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Characterization of 2',7'-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Chaperone-like activity of synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0752546.X

10.1046/J.1471-4159.2000.0752546.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference